Aridis Pharmaceuticals Inc (OTCPK:ARDS)
$ 0.06342 0.010924 (20.81%) Market Cap: 2.83 Mil Enterprise Value: 7.14 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Aridis Pharmaceuticals Inc Investor Update Call Transcript

Jan 27, 2022 / 09:15PM GMT
Release Date Price: $2.01 (+15.52%)
Operator;Vu Truong

Thank you for standing by. This is the conference operator. Welcome to Aridis Pharmaceuticals' investor update conference call. All participants are in a listen-only mode. The conference is being recorded. The call will be open for Q&A following management's presentation. On today's call are Aridis Pharmaceuticals' CEO, Vu Truong; and CFO, Fred Kurland.

Before we begin, I would like to remind everybody that this call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements pertaining to future financial and/or operating results, along with other statements about the future expectations, beliefs, goals, plans or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact should also be considered forward-looking statements, and forward-looking statements involve risks and uncertainties.

I would now like to turn the call over to Dr. Vu Truong, Aridis Pharmaceuticals' Chief Executive Officer. Dr. Truong, please go ahead.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot